The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
FDG and PSMA PET in metastatic castration-resistant prostate cancer (mCRPC).
 
Katherine A. Zukotynski
No Relationships to Disclose
 
Hossein Jadvar
Research Funding - Subtle Medical (Inst)
 
Steve Y. Cho
Research Funding - GE Healthcare
 
Chun Ki Kim
No Relationships to Disclose
 
Kathryn Cline
No Relationships to Disclose
 
Urban Emmenegger
Honoraria - Amgen; Astellas Pharma; Bayer; Janssen
Consulting or Advisory Role - Amgen; Astellas Pharma; Bayer; Ferring; Janssen; Sanofi
Research Funding - Astellas Pharma; Bayer; Janssen
 
Sebastien J. Hotte
Honoraria - Astellas Scientific and Medical Affairs Inc; Bayer; Eisai; Janssen Oncology
Consulting or Advisory Role - Astellas Pharma; AstraZeneca; Bayer; Bristol-Myers Squibb; Eisai; Janssen; Merck; Pfizer; Roche Canada
Research Funding - AstraZeneca; Ayala Pharmaceuticals; Bayer; Bristol-Myers Squibb; Clovis Oncology; Janssen Oncology; Merck; Pfizer (Inst); Roche/Genentech
Travel, Accommodations, Expenses - Eisai
 
Gregory Russell Pond
Employment - Roche Canada (I)
Stock and Other Ownership Interests - Roche Canada (I)
Consulting or Advisory Role - Bayer; Takeda
 
Eric Winquist
Honoraria - Amgen; Bayer; Eisai; Merck; Roche
Research Funding - AstraZeneca/MedImmune (Inst); Bristol-Myers Squibb (Inst); Eisai (Inst); Merck (Inst); Pfizer (Inst); Roche/Genentech (Inst)